Some participants may take part in two optional substudies. In one substudy, participants will attend two study visits at entry/Day 0 and Week 4 for 12-hour intensive pharmacokinetic (PK) sampling. In another substudy, participants will undergo liver biopsies at two time points and PK sampling.